Elena Brioni

Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study

Rebecca De Lorenzo, Caterina Conte, Chiara Lanzani et al. · PLoS ONE · 2020 · 180 citations · Full text

Covid-19 Epidemiology, Covid-19, Residual Clinical Damage +19

Physiological Interaction Between α-Adducin and <i>WNK1-NEDD4L</i> Pathways on Sodium-Related Blood Pressure Regulation

Paolo Manunta, Gail Lavery, Chiara Lanzani et al. · Hypertension · 2008 · 89 citations · Full text

Hypertension, Genetics, Renal Pathology +23

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 74 citations · Full text

Post-COVID-19 follow-up clinic: depicting chronicity of a new disease.

Patrizia Rovere‐Querini, Rebecca De Lorenzo, Caterina Conte et al. · PubMed · 2020 · 70 citations · Full text